Document:

Exhibit 10.17

 

			
	

	
 
	
Akebia Therapeutics, Inc.

245 First Street, Suite 1100

Cambridge, MA 02142

T: +1 617.871.2098 F: +1 617.871.2099 

www.akebia.com

July 21, 2014

Bradley Maroni, M.D.

8 Durham Street

Boston, MA 02115

Dear Brad:

It is my pleasure to extend the following offer of employment to you on behalf of Akebia Therapeutics, Inc. (“Akebia” or the “Company”).  Akebia is proud of its achievements to date and we are looking to individuals such as you to play a supporting role in advancing our exciting product candidates.   We are confident that you will make an immediate impact and be a productive member of our team.

This offer letter (the “Offer Letter”) confirms to you Akebia’s offer of employment, the terms of which are as follows:

	
1.
	
Position.  You will be employed in the full-time, salaried exempt position of Sr. Vice President & Chief Medical Officer reporting to John Butler, President and CEO, and based in our Cambridge, Massachusetts office.  We expect that you will perform any and all duties and responsibilities typically associated with your position, and any other duties assigned to you, in a satisfactory manner and to the best of your abilities at all times. As you progress with the Company, your position, location and assignments are, of course, subject to change.   

	
2.
	
Start Date.  Your employment will begin on August 18, 2014 (“Start Date”).

	
3.
	
Compensation. Your initial compensation will include the following: 

	
(i)
	
You will be paid a base salary of $400,000 per year, paid bi-weekly;     

	
(ii)
	
You will be considered annually for a performance-based, cash bonus of up to 30% of your base salary; and 

	
(iii)
	
Subject to approval by the Board of Directors, you will be granted a non-statutory option to purchase 125,000 shares of common stock of the Company, with an exercise price equal to the fair market value of a share of Company stock on the date of grant and subject to the terms of a stock option agreement between you and the Company.

	
4.
	
Benefits.  As a full-time employee, during your employment with the Company you will be entitled to participate in all applicable benefit programs currently offered by Akebia and for which you are eligible. The Company is committed to providing competitive benefits to its employees.  The Company currently offers health care and dental insurance to full-time employees (and their spouses and dependents)  and a 401(k) savings plan, which allows employees to contribute a portion of their pre-tax wages to a retirement account, up to the maximum permitted by law.  The Company will also provide you with paid time off (PTO) in accordance with its policies as in effect from time to time (currently twenty (20) days per calendar year), plus those holidays observed by the Company.  Your eligibility to participate in and receive any particular benefit is subject to, and governed solely by, the applicable plan document.  We will provide separately more detailed information regarding the current terms and conditions of our benefit plans, and information regarding any future additions or modifications to our benefit plans will be provided when available.  The Company reserves the right to modify, change or terminate its benefits and benefit plans from time to time in its sole discretion.   

	
5.
	
Taxes.  All forms of compensation referred to in this Offer Letter are subject to reduction to reflect applicable taxes and other withholdings and deductions.  You hereby acknowledge that the Company does not have a duty to design its compensation policies in a manner that minimizes your tax liabilities, and you will not make any claim against the Company or its Board of Directors (or any of its or their respective agents, delegates and representatives) related to tax liabilities arising from your compensation.

	
6.
	
Contingencies.  Pursuant to the Immigration and Reform Control Act of 1986, and within three days after your Start Date, you must provide sufficient documentation of your ability to work legally in the U.S.   This employment offer is also contingent upon the results of any reference and background checks.  

	
7.
	
Employment at Will.  This offer of employment is not intended to create a contract of employment.  Your employment will be at-will and both you and Akebia will have the right to terminate the employment relationship at any time, with or without reason or notice. 

			
	

	
 
	
Akebia Therapeutics, Inc.

245 First Street, Suite 1100

Cambridge, MA 02142

T: +1 617.871.2098 F: +1 617.871.2099 

www.akebia.com

 

	
8.
	
Covenants.  This offer of employment is contingent upon your execution of an Employee Agreement (Confidentiality, Non-Solicitation, Non-Competition and Developments Agreement), a copy of which will be provided to you and which you must sign and return prior to your Start Date.  

	
9.
	
Entire Agreement, Amendments. This Offer Letter constitutes the complete agreement between you and the Company, contains all of the terms of your employment with the Company and supersedes any prior agreements, representations or understandings (whether written, oral or implied) between you and the Company.  No variations, modifications or amendments to this Offer Letter shall be deemed valid unless reduced to writing and signed by the Company and you, provided that your employment will remain at-will unless otherwise set forth in a writing signed by the Company’s Chief Executive Officer.  We will be providing you with an Executive Severance Agreement (“ESA”) for your review and signature.  In the event of a conflict between the terms of this Offer Letter and the terms of the ESA, the terms of the ESA will govern.

To indicate acceptance of these terms, please sign and return a copy of this letter (via fax, pdf or regular mail). 

Brad, we look forward to you joining Akebia.  Teamwork, quality people and a business focus are all critical to Akebia's success.  We are confident that you will play an important role in the future of our Company.

 

	
	
Very truly yours,

	
 

	

	
 

	
John P. Butler

	
President & CEO

Response requested by July 24, 2014

I accept the above employment offer and agree to its terms and conditions.  By accepting this offer of employment, I acknowledge that no prior employment obligations or other contractual restrictions exist which preclude my employment with Akebia Therapeutics, Inc.  I further understand that this offer is confidential and that my disclosure of any of its terms and conditions may result in termination of my employment or withdrawal of this offer.  I represent that I am not relying on any representations made to me by anyone other than as set forth above.

Accepted:

 

	
/s/ Bradley Maroni
	
 
	
Date:
	
 
	
7/24/14
	
 

	
Bradley Maroni, M.D.Exhibit 10.26

Restricted Stock Unit Award 

granted under the

AKEBIA THERAPEUTICS, INC.
2014 Incentive Plan

Restricted Stock Unit Award Agreement

This agreement (the “Agreement”) evidences the grant of a restricted stock unit award by Akebia Therapeutics, Inc. (the “Company”) to the undersigned (the “Participant”), pursuant to and subject to the terms of the Akebia Therapeutics, Inc. 2014 Incentive Plan (as amended from time to time, the “Plan”).  For purposes of this Agreement, the “Grant Date” will mean [●].

1. Restricted Stock Unit Award.  The Participant is hereby awarded, pursuant to the Plan and subject to its terms, a Restricted Stock Unit award (the “Award”) giving the Participant the conditional right to receive, without payment but subject to the conditions and limitations set forth in this Agreement and in the Plan, [●] shares of Stock of the Company (the “Shares”).  

2. Meaning of Certain Terms.  Except as otherwise defined herein, all capitalized terms used herein have the same meaning as in the Plan.  For purposes of this Award, the following terms have the following meanings:

(a) “Change in Control” means the occurrence of any of the following events other than in connection with the consummation of an initial public offering of the Company’s securities: (i) any “person” (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended) who is not a shareholder of the Company as of the date of this Agreement or an affiliate thereof is or becomes the “beneficial owner” (as defined in Rule 13d-3 under said Act), directly or indirectly, of securities of the Company representing 50% or more of the total voting power represented by the Company’s then outstanding voting securities; (ii) a change in the composition of the Board occurring within a two-year period, as a result of which less than a majority of the directors are Incumbent Directors; (iii) the date of the consummation of a merger, scheme of arrangement or consolidation of the Company with any other corporation that has been approved by the stockholders of the Company, other than a merger, scheme of arrangement or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation; or (iv) the date of the consummation of the sale or disposition by the Company of all or substantially all the Company’s assets.  Notwithstanding the foregoing, a transaction will not constitute a Change in Control if: (i) its sole purpose is to change the domicile of the Company’s incorporation; or (ii) its sole purpose is to create a holding company that will be owned in substantially the same proportions by the persons who held the Company’s securities immediately before such transaction.  In all respects, the definition of Change in Control will be interpreted to comply with Section 409A of the Code, and any successor statute, regulation and guidance thereto.    

(b) “Good Reason” has the same meaning as under the Executive Severance Agreement between the Participant and the Company or, if the Participant is not party to an Executive Severance Agreement with the Company, means a material diminishment of his or her job responsibilities or duties, or base compensation.

(c) “Incumbent Directors” means directors who either (A) are directors of the Company as of the date hereof, or (B) are elected, or nominated for election, to the Board with the affirmative votes of at least a majority of the remaining Incumbent Directors at the time of such election or nomination (but will not include an individual whose election or nomination is in connection with an actual or threatened proxy contest relating to the election of directors to the Company). 

3. Vesting.  Unless earlier terminated, forfeited, relinquished or expired, and subject to Section 6 of this Agreement and the terms of any Executive Severance Agreement or other written agreement between the Participant and the Company, the Award will become vested, subject to the Participant’s continuous Employment though the applicable vesting date, as follows: 

(a) 100% of the Award will become vested on the third anniversary of the Grant Date.  

(b) Notwithstanding the foregoing Section 3(a), following the occurrence of a Change in Control, the Award will become fully vested in the event that the Participant is terminated without Cause or terminates his or her Employment for Good Reason.  Such vesting acceleration will take place automatically and immediately on the date of such termination of Employment without Cause or for Good Reason, as the case may be, so that the Award will be fully vested upon such termination.  

4. Delivery of Shares.  Subject to Section 6 of this Agreement, the Company will, within thirty (30) days of the vesting date described in Section 3 with respect to any portion of the Award, effect delivery of the Shares with respect to such vested portion to the 

 

 

Participant (or, in the event of the Participant’s death, to the person to whom the Award has passed by will or the laws of descent and distribution).  No Shares will be issued pursuant to this Award unless and until all legal requirements applicable to the issuance or transfer of such Shares have been complied with to the satisfaction of the Administrator.  

5. Dividends; Other Rights.  The Award will not be interpreted to bestow upon the Participant any equity interest or ownership in the Company or any Affiliate prior to the date on which the Company delivers Shares to the Participant.  The Participant is not entitled to vote any Shares by reason of the granting of this Award or to receive or be credited with any dividends declared and payable on any Share prior to the payment date with respect to such Share.  The Participant will have the rights of a shareholder only as to those Shares, if any, that are actually delivered under this Award.

6. Treatment of Award Upon Cessation of Employment.  If the Participant’s Employment ceases, the Award, to the extent not already vested, will be immediately forfeited.  Notwithstanding the foregoing, to the extent the Participant is a party to an Executive Severance Agreement or other written agreement with the Company that provides for the Award to remain outstanding and continue to vest during a specified period of time following the Participant’s cessation of Employment (such period, the “Severance Period”), the Award will remain outstanding and will continue to vest, and Shares will be delivered upon such vesting, in accordance with the terms of this Agreement during the Severance Period as if the Participant had remained employed during such period, subject to any conditions on continued vesting and delivery as may be contained in such Executive Severance Agreement or other written agreement.  For the avoidance of doubt, any portion of the Award that fails to vest during the Severance Period will immediately be forfeited on the last day of such period.

7. Certain Tax Matters.  

(a) The Participant expressly acknowledges that because this Award consists of an unfunded and unsecured promise by the Company to deliver Shares in the future, subject to the terms hereof, it is not possible to make a so-called “83(b) election” with respect to the Award.  In no event will the Company have any liability relating to the failure or alleged failure of any payment or benefit under this Agreement to comply with, or be exempt from, the requirements of Section 409A.  

(b) Notwithstanding anything to the contrary in this Award, if at the time of the Participant’s termination of Employment, the Participant is a “specified employee,” as defined below, any and all amounts payable under this Award on account of such separation from service that constitute deferred compensation and would (but for this provision) be payable within six (6) months following the date of termination, will instead be paid on the next business day following the expiration of such six (6) month period or, if earlier, upon the Participant’s death; except (A) to the extent of amounts that do not constitute a deferral of compensation within the meaning of Treasury Regulation Section 1.409A-1(b) or (B) other amounts or benefits that are not subject to the requirements of Section 409A.

(c) For purposes of this Award, all references to “termination of employment” and correlative phrases will be construed to require a “separation from service” (as defined in Section 1.409A-1(h) of the Treasury Regulations after giving effect to the presumptions contained therein), and the term “specified employee” means an individual determined by the Company to be a specified employee under Treasury Regulation Section 1.409A-1(i).  

(d) The award, vesting or delivery of the Shares acquired hereunder may give rise to “wages” subject to withholding.  The Participant expressly acknowledges and agrees that his or her rights hereunder, including the right to be delivered Shares upon vesting, are subject to the Participant promptly paying the Company in cash (or by such other means as may be acceptable to the Administrator in its discretion) all taxes required to be withheld.  No Shares will be delivered pursuant to this Award unless and until the Participant will have remitted to the Company in cash or by check an amount sufficient to satisfy any federal, state or local withholding tax requirements or tax payments, or will have made other arrangements satisfactory to the Administrator with respect to such taxes.  The Administrator may, in its sole discretion, hold back Shares from an award or permit the Participant to tender previously owned shares of Stock in satisfaction of tax withholding or tax payment requirements (but not in excess of the applicable minimum statutory withholding rate).

8. Forfeiture; Recovery of Compensation. 

(a) The Administrator may cancel, rescind, withhold or otherwise limit or restrict the Award at any time if the Participant is not in compliance with all applicable provisions of this Agreement and the Plan, or if the Participant breaches any agreement with the Company or its subsidiaries with respect to non-competition, non-solicitation, invention assignment or confidentiality, including, but not limited to, any employment agreement or offer letter with the Company or the Company’s standard Employee Agreement (Confidentiality, Non-Solicitation, Non-Competition and Developments Agreement).

-2-

 

(b) By accepting the Award, the Participant expressly acknowledges and agrees that his or her rights, and those of any permitted transferee of the Award, under the Award, including to any Stock delivered under the Award or proceeds from the disposition thereof, are subject to Section 6(a)(5) of the Plan (including any successor provision).  Nothing in the preceding sentence will be construed as limiting the general application of Section 11 of this Agreement.

9. Transfer of Award.  The Award may not be transferred except as expressly permitted under Section 6(a)(3) of the Plan.

10. Effect on Employment.  Neither the grant of this Award, nor the delivery of Shares under this Award, will give the Participant any right to be retained in the employ or service of the Company or any of its Affiliates, affect the right of the Company or any of its Affiliates to discharge or discipline such Participant at any time, or affect any right of such Participant to terminate his or her Employment at any time.

11. Provisions of the Plan.  This Agreement is subject in its entirety to the provisions of the Plan, which are incorporated herein by reference.  A copy of the Plan as in effect on the Grant Date has been furnished to the Participant.  By accepting this Award, the Participant agrees to be bound by the terms of the Plan and this Agreement.  In the event of any conflict between the terms of this Agreement and the Plan, the terms of the Plan will control. 

12. Provisions of Executive Severance Agreement. To the extent the Participant has entered into an Executive Severance Agreement with the Company, for so long as such Executive Severance Agreement remains in effect, the terms of such Executive Severance Agreement as they relate to the Award will control in the event of any conflict with the terms of this Agreement.

13. Acknowledgements.  The Participant acknowledges and agrees that (i) this Agreement may be executed in two or more counterparts, each of which will be an original and all of which together will constitute one and the same instrument, (ii) this agreement may be executed and exchanged using facsimile, portable document format (PDF) or electronic signature, which, in each case, will constitute an original signature for all purposes hereunder and (iii) such signature by the Company will be binding against the Company and will create a legally binding agreement when this Agreement is countersigned by the Participant. 

[Signature page follows.]

 

 

 

-3-

 

IN WITNESS WHEREOF, the Company has caused this Agreement to be executed by its duly authorized officer.  

 

	
AKEBIA THERAPEUTICS, INC.

	
 
	
 
	
 

	
By:
	
 
	
 

	
Name:
	
 
	
[●]

	
Title:
	
 
	
[●]

Dated:  

Acknowledged and Agreed:

 

	
By:
	
 
	
 

	
 
	
 
	
[Participant’s Name]

 

 

 

[Signature Page to Restricted Stock Unit Award Agreement]

 

Officer Restricted Stock Unit Award 

granted under the

AKEBIA THERAPEUTICS, INC.
2014 Incentive Plan

Restricted Stock Unit Award Agreement

This agreement (the “Agreement”) evidences the grant of a restricted stock unit award by Akebia Therapeutics, Inc. (the “Company”) to the undersigned (the “Participant”), pursuant to and subject to the terms of the Akebia Therapeutics, Inc. 2014 Incentive Plan (as amended from time to time, the “Plan”).  For purposes of this Agreement, the “Grant Date” will mean [●].

14. Restricted Stock Unit Award.  The Participant is hereby awarded, pursuant to the Plan and subject to its terms, a Restricted Stock Unit award (the “Award”) giving the Participant the conditional right to receive, without payment but subject to the conditions and limitations set forth in this Agreement and in the Plan, [●] shares of Stock of the Company (the “Shares”).  

15. Meaning of Certain Terms.  Except as otherwise defined herein, all capitalized terms used herein have the same meaning as in the Plan.  For purposes of this Award, the following terms have the following meanings:

(a) “Change in Control” means the occurrence of any of the following events other than in connection with the consummation of an initial public offering of the Company’s securities: (i) any “person” (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended) who is not a shareholder of the Company as of the date of this Agreement or an affiliate thereof is or becomes the “beneficial owner” (as defined in Rule 13d-3 under said Act), directly or indirectly, of securities of the Company representing 50% or more of the total voting power represented by the Company’s then outstanding voting securities; (ii) a change in the composition of the Board occurring within a two-year period, as a result of which less than a majority of the directors are Incumbent Directors; (iii) the date of the consummation of a merger, scheme of arrangement or consolidation of the Company with any other corporation that has been approved by the stockholders of the Company, other than a merger, scheme of arrangement or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation; or (iv) the date of the consummation of the sale or disposition by the Company of all or substantially all the Company’s assets.  Notwithstanding the foregoing, a transaction will not constitute a Change in Control if: (i) its sole purpose is to change the domicile of the Company’s incorporation; or (ii) its sole purpose is to create a holding company that will be owned in substantially the same proportions by the persons who held the Company’s securities immediately before such transaction.  In all respects, the definition of Change in Control will be interpreted to comply with Section 409A of the Code, and any successor statute, regulation and guidance thereto.    

(b) “Incumbent Directors” means directors who either (A) are directors of the Company as of the date hereof, or (B) are elected, or nominated for election, to the Board with the affirmative votes of at least a majority of the remaining Incumbent Directors at the time of such election or nomination (but will not include an individual whose election or nomination is in connection with an actual or threatened proxy contest relating to the election of directors to the Company). 

16. Vesting.  Unless earlier terminated, forfeited, relinquished or expired, and subject to Section 6 of this Agreement and the terms of any Executive Severance Agreement or other written agreement between the Participant and the Company, the Award will become vested, subject to the Participant’s continuous Employment though the applicable vesting date, as follows: 

(a) 100% of the Award will become vested on the third anniversary of the Grant Date.  

(b) Notwithstanding the foregoing Section 3(a), the Award, to the extent outstanding immediately prior to a Change in Control but not then vested in full, will automatically and immediately become fully vested upon such Change in Control.

17. Delivery of Shares.  Subject to Section 6 of this Agreement, the Company will, within thirty (30) days of the vesting date described in Section 3 with respect to any portion of the Award, effect delivery of the Shares with respect to such vested portion to the Participant (or, in the event of the Participant’s death, to the person to whom the Award has passed by will or the laws of descent and distribution).  No Shares will be issued pursuant to this Award unless and until all legal requirements applicable to the issuance or transfer of such Shares have been complied with to the satisfaction of the Administrator.  

18. Dividends; Other Rights.  The Award will not be interpreted to bestow upon the Participant any equity interest or ownership in the Company or any Affiliate prior to the date on which the Company delivers Shares to the Participant.  The Participant is not entitled to vote any Shares by reason of the granting of this Award or to receive or be credited with any dividends declared and 

-5-

 

payable on any Share prior to the payment date with respect to such Share.  The Participant will have the rights of a shareholder only as to those Shares, if any, that are actually delivered under this Award.

19. Treatment of Award Upon Cessation of Employment.  If the Participant’s Employment ceases, the Award, to the extent not already vested, will be immediately forfeited.  Notwithstanding the foregoing, to the extent the Participant is a party to an Executive Severance Agreement or other written agreement with the Company that provides for the Award to remain outstanding and continue to vest during a specified period of time following the Participant’s cessation of Employment (such period, the “Severance Period”), the Award will remain outstanding and will continue to vest, and Shares will be delivered upon such vesting, in accordance with the terms of this Agreement during the Severance Period as if the Participant had remained employed during such period, subject to any conditions on continued vesting and delivery as may be contained in such Executive Severance Agreement or other written agreement.  For the avoidance of doubt, any portion of the Award that fails to vest during the Severance Period will immediately be forfeited on the last day of such period.

20. Certain Tax Matters.  

(a) The Participant expressly acknowledges that because this Award consists of an unfunded and unsecured promise by the Company to deliver Shares in the future, subject to the terms hereof, it is not possible to make a so-called “83(b) election” with respect to the Award.  In no event will the Company have any liability relating to the failure or alleged failure of any payment or benefit under this Agreement to comply with, or be exempt from, the requirements of Section 409A.  

(b) Notwithstanding anything to the contrary in this Award, if at the time of the Participant’s termination of Employment, the Participant is a “specified employee,” as defined below, any and all amounts payable under this Award on account of such separation from service that constitute deferred compensation and would (but for this provision) be payable within six (6) months following the date of termination, will instead be paid on the next business day following the expiration of such six (6) month period or, if earlier, upon the Participant’s death; except (A) to the extent of amounts that do not constitute a deferral of compensation within the meaning of Treasury Regulation Section 1.409A-1(b) or (B) other amounts or benefits that are not subject to the requirements of Section 409A.

(c) For purposes of this Award, all references to “termination of employment” and correlative phrases will be construed to require a “separation from service” (as defined in Section 1.409A-1(h) of the Treasury Regulations after giving effect to the presumptions contained therein), and the term “specified employee” means an individual determined by the Company to be a specified employee under Treasury Regulation Section 1.409A-1(i).  

(d) The award, vesting or delivery of the Shares acquired hereunder may give rise to “wages” subject to withholding.  The Participant expressly acknowledges and agrees that his or her rights hereunder, including the right to be delivered Shares upon vesting, are subject to the Participant promptly paying the Company in cash (or by such other means as may be acceptable to the Administrator in its discretion) all taxes required to be withheld.  No Shares will be delivered pursuant to this Award unless and until the Participant will have remitted to the Company in cash or by check an amount sufficient to satisfy any federal, state or local withholding tax requirements or tax payments, or will have made other arrangements satisfactory to the Administrator with respect to such taxes.  The Administrator may, in its sole discretion, hold back Shares from an award or permit the Participant to tender previously owned shares of Stock in satisfaction of tax withholding or tax payment requirements (but not in excess of the applicable minimum statutory withholding rate).

21. Forfeiture; Recovery of Compensation. 

(a) The Administrator may cancel, rescind, withhold or otherwise limit or restrict the Award at any time if the Participant is not in compliance with all applicable provisions of this Agreement and the Plan, or if the Participant breaches any agreement with the Company or its subsidiaries with respect to non-competition, non-solicitation, invention assignment or confidentiality, including, but not limited to, any employment agreement or offer letter with the Company or the Company’s standard Employee Agreement (Confidentiality, Non-Solicitation, Non-Competition and Developments Agreement).

(b) By accepting the Award, the Participant expressly acknowledges and agrees that his or her rights, and those of any permitted transferee of the Award, under the Award, including to any Stock delivered under the Award or proceeds from the disposition thereof, are subject to Section 6(a)(5) of the Plan (including any successor provision).  Nothing in the preceding sentence will be construed as limiting the general application of Section 11 of this Agreement.

22. Transfer of Award.  The Award may not be transferred except as expressly permitted under Section 6(a)(3) of the Plan.

-6-

 

23. Effect on Employment.  Neither the grant of this Award, nor the delivery of Shares under this Award, will give the Participant any right to be retained in the employ or service of the Company or any of its Affiliates, affect the right of the Company or any of its Affiliates to discharge or discipline such Participant at any time, or affect any right of such Participant to terminate his or her Employment at any time.

24. Provisions of the Plan.  This Agreement is subject in its entirety to the provisions of the Plan, which are incorporated herein by reference.  A copy of the Plan as in effect on the Grant Date has been furnished to the Participant.  By accepting this Award, the Participant agrees to be bound by the terms of the Plan and this Agreement.  In the event of any conflict between the terms of this Agreement and the Plan, the terms of the Plan will control. 

25. Provisions of Executive Severance Agreement. To the extent the Participant has entered into an Executive Severance Agreement with the Company, for so long as such Executive Severance Agreement remains in effect, the terms of such Executive Severance Agreement as they relate to the Award will control in the event of any conflict with the terms of this Agreement.

26. Acknowledgements.  The Participant acknowledges and agrees that (i) this Agreement may be executed in two or more counterparts, each of which will be an original and all of which together will constitute one and the same instrument, (ii) this agreement may be executed and exchanged using facsimile, portable document format (PDF) or electronic signature, which, in each case, will constitute an original signature for all purposes hereunder and (iii) such signature by the Company will be binding against the Company and will create a legally binding agreement when this Agreement is countersigned by the Participant. 

[Signature page follows.]

 

 

 

-7-

 

IN WITNESS WHEREOF, the Company has caused this Agreement to be executed by its duly authorized officer.  

 

	
AKEBIA THERAPEUTICS, INC.

	
 
	
 
	
 

	
By:
	
 
	
 

	
Name:
	
 
	
[●]

	
Title:
	
 
	
[●]

Dated:  

Acknowledged and Agreed:

 

	
By:
	
 
	
 

	
 
	
 
	
[Participant’s Name]

 

[Signature Page to Restricted Stock Unit Award Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}]]